Cardinal Health stock is trading -8.76% below its average target price of $114.08 after marking a 3.1% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical company an average rating of buy and target prices ranging from $95.0 to $129.0 per share.
The stock has an average amount of shares sold short at 4.4%, and a short ratio of 3.74. The company's insiders own 0.58% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 91.4% of Cardinal Health's shares being owned by this investor type.
Institutions Invested in Cardinal Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 13% | 30,620,279 | $3,187,264,728 |
| 2024-03-31 | Blackrock Inc. | 11% | 27,335,699 | $2,845,372,808 |
| 2024-03-31 | State Street Corporation | 6% | 14,112,384 | $1,468,957,998 |
| 2024-03-31 | FMR, LLC | 2% | 5,796,164 | $603,322,689 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 5,574,144 | $580,212,628 |
| 2024-03-31 | Morgan Stanley | 2% | 4,366,078 | $454,465,043 |
| 2024-03-31 | Arrowstreet Capital, Limited Partnership | 2% | 4,140,014 | $430,934,042 |
| 2024-03-31 | Pacer Advisors, Inc. | 2% | 3,728,901 | $388,141,291 |
| 2024-03-31 | Acadian Asset Management. LLC | 2% | 3,723,159 | $387,543,606 |
| 2024-03-31 | Ameriprise Financial, Inc. | 1% | 3,623,872 | $377,208,823 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Cardinal Health.
